Key Questions

As neuroethics enters its second decade, the field confronts new techniques and technologies, as well as new – and frequently controversial – clinical treatments. Keeping in mind that the foremost goal is to improve patient care, brain scientists, clinicians, ethicists and legal scholars will address the newest developments and application of: neuroimaging, neurogenomics, predictive biomarkers, neuromodulation, brain-computer interfacing, and neuropsychopharmacology.

 

 

 Through the latest uses of these approaches, and analysis of paradigmatic cases, discussion will center upon what these advances mean for patients – and society – both at present and in the near future.